NDC 72162-1704 – Acyclovir

Acyclovir 200 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC72162-1704

Product details

Brand name
Acyclovir
Generic name
Acyclovir
Labeler
Bryant Ranch Prepack
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075677
Marketed since
March 20, 2006
Marketing end
April 30, 2027
Pharmacologic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Acyclovir →

Package NDC codes (10)

Package NDCDescriptionSince
72162-1704-0120 CAPSULE in 1 BOTTLE (72162-1704-0)Mar 25, 2026
72162-1704-1100 CAPSULE in 1 BOTTLE (72162-1704-1)Mar 25, 2026
72162-1704-225 CAPSULE in 1 BOTTLE (72162-1704-2)Mar 25, 2026
72162-1704-330 CAPSULE in 1 BOTTLE (72162-1704-3)Mar 25, 2026
72162-1704-435 CAPSULE in 1 BOTTLE (72162-1704-4)Mar 25, 2026
72162-1704-520 CAPSULE in 1 BOTTLE (72162-1704-5)Mar 25, 2026
72162-1704-660 CAPSULE in 1 BOTTLE (72162-1704-6)Mar 25, 2026
72162-1704-750 CAPSULE in 1 BOTTLE (72162-1704-7)Mar 25, 2026
72162-1704-840 CAPSULE in 1 BOTTLE (72162-1704-8)Mar 25, 2026
72162-1704-990 CAPSULE in 1 BOTTLE (72162-1704-9)Mar 25, 2026

Other Acyclovir products